Director, Interim Chief Executive Officer
Mr. Edwards is the founder and President of VetRx, a Montreal-based technology company specializing in data collection, cleansing, marketing and pharmaceutical compliance for the veterinary industry. Mr. Edwards holds a Bachelor's degree (Finance) from l'Université de Sherbrooke and an MBA from Concordia University.
Chief Financial Officer
Ray Dupuis joined Kane Biotech as Chief Financial Officer in September 2017. Mr. Dupuis has more than 25 years of financial leadership experience across a broad range of industries including 15 years at a rapidly growing public biotechnology company and brings to the organization considerable financial acumen and strategic skills. Mr. Dupuis is a Chartered Professional Accountant (CPA, CGA) and possesses Bachelor of Science (Biology), Bachelor of Arts (Administrative Studies) and Master of Business Administration (Finance) degrees.
Gordon Guay, Ph.D.
Chief Scientific Officer
Gordon has over twenty-five years of experience in R&D and new product development. He has worked as a Research Fellow at Proctor and Gamble, serving as the lead scientist within a range of different P&G business units including: Oral-B, Gillette, Olay, Right Guard, CoverGirl, Max Factor and Duracell. Gordon has received over 11 international awards for new products developed during his tenure at P&G. Prior to P&G, Gordon was the Director of Research at Catalytic Antibodies Inc.
Gordon received a Ph.D. in molecular genetics from the University of Illinois. His research focused on bacterial resistance to sulfonamides. He also conducted post-Doctoral work at Lederle Laboratories on substrate specificity of tetracycline efflux pumps.
Vice President, Sales
Grant Humphrey joined Kane Biotech as Vice President, Sales in July, 2016. Mr. Humphrey is an accomplished, award winning sales professional. An entrepreneur, he has invented, patented and developed a product from conception to market that is still being sold today. He possesses a hunter-like mentality that allows him to meet and exceed sales targets, and his ability to build relationships leads to successful partnerships across many industries both domestically and internationally. He has experiences in veterinary and human healthcare, B2B and B2G marketing programs.
Senior Research Scientist
Nanda Yakandawala joined Kane Biotech in 2003 and leads the Company's research efforts. Originally graduating with his B.Sc. from the University of Peradeniya in Sri Lanka, Dr. Yakandawala completed his M.Sc. in biotechnology at the University of Adelaide in Australia followed by his Ph.D. in molecular biology at the Swiss Federal Institute in Zurich. Dr. Yakandawala is a recognized expert in biofilms and is widely published in his field.
Wendy Nachtigall joined Kane Biotech in October 2015 as Director, Retail. With 15+ years in the marketing communications industry, Ms. Nachtigall brings a wealth of knowledge and expertise in planning, implementing and evaluating strategic marketing and communications initiatives in the consumer, institutional and B2B sectors, including new product and service introductions, brand development strategies and growth of business. Ms. Nachtigall has a proven track record in project management, as well as developing and maintaining long-term business relationships.
Director, Regulatory and Quality Control
Andrea Gordon joined Kane Biotech as Director, Regulatory and Quality Control in July 2015. Ms. Gordon has been working in the field of quality assurance and regulatory compliance for over 15 years in a variety of disciplines including telecommunications, medical devices, and devices intended for use in explosive atmospheres. Ms. Gordon holds a Bachelor of Science (Computer Engineering) and a Certificate in Quality Management from the University of Manitoba.